current affair stromectol

A phase II, randomised trial of trastuzumab, with or without celecoxib, in a series of 12 patients with metastatic breast cancer who had previously progressed after trastuzumab based treatments, found that there was no treatment effect, although the drug combination was well tolerated Dang et al, 2004 who manufactures stromectol